The AYA Oncology Self-care Movement for ALL
This study is looking at how social media can help young people (ages 15-25) with acute lymphoblastic leukemia (ALL) remember to take their 6-mercaptopurine (a chemotherapy medicine). You could join if you have ALL, are taking 6-mercaptopurine, and have at least six months left of this treatment. You also need to speak and read English and have an active social media account. The study will test an educational website and social media messages (#AYAOSM) designed to improve how well you take your medicine. We'll know if the interventions are successful by tracking how consistently you take your medicine over six months.
- Study design
- This interventional study plans to include 200 participants aged 15-25. It will compare an educational website and social media messages to see their impact on medication adherence.
- What's involved
- You will complete a baseline questionnaire online and use an electronic monitor to track your 6-mercaptopurine adherence daily for six months. There will also be a 28-day run-in period where only adherence is monitored.
- Compensation
- Not stated in the trial record.
- Follow-up
- Your medication adherence will be monitored for six months.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
The AYA Oncology Self-care Movement
At a glance
Conditions
NCT07724652
Where you'd take part
This study runs at 4 sites. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
Ann & Robert H. Lurie Children's Hospital of Chicago
Chicago, Illinoisstudy coordinator listed
MD Anderson Cancer Center
Houston, Texasstudy coordinator listed
Northwestern University
Chicago, Illinoisstudy coordinator listed
The Children's Hospital of Philadelphia
Philadelphia, Pennsylvaniastudy coordinator listed
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Want this trial checked against your situation?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Electronically-monitored Medication Adherence6-months
6-mercaptopurine (6-MP) adherence will be assessed using a Medication Event Monitoring System (MEMS), an electronic pill bottle cap that records bottle openings with date and time stamps. Adherence will be calculated as the percentage of prescribed days with a recorded bottle opening (number of days with openings/number of prescribed days × 100). The primary analysis will evaluate the proportion of participants achieving the clinically meaningful threshold of ≥95% adherent.